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Background: There are large differences in pregnancy outcome between high income countries and many middle
and low income countries. In fact, maternal, fetal and neonatal mortality rates in many low-income countries
approximate those that were seen in high-income countries nearly a century ago.
Findings: This paper documents the very substantial reductions in maternal, fetal and neonatal mortality rates in high
income countries over the last century and explores the likely reasons for those reductions. The conditions responsible
for the current high mortality rates in low and middle income countries are discussed as are the interventions likely to
result in substantial reductions in maternal, fetal and neonatal mortality from those conditions. The conditions that
result in maternal mortality are often responsible for fetal and neonatal mortality and the interventions that save
maternal lives often reduce fetal and neonatal mortality as well. Single interventions rarely achieve substantial
reductions in mortality. Instead, upgrading the system of care so that appropriate interventions could be applied at
appropriate times is most likely to achieve the desired reductions in maternal, fetal and neonatal mortality.
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In many low-income countries, the maternal mortality ra-
tios are 100-fold greater than in high-income countries
(HIC) [1]. Rates of fetal and neonatal mortality are often
10-fold greater or more [2-5]. Current low-income coun-
try (LIC) maternal, fetal and neonatal mortality rates are
generally similar to the HIC rates eighty to one hun-
dred years ago [6,7]. This paper explores reasons that
the rates of each of these outcomes have fallen in HIC
and reviews the medical causes of maternal and neo-
natal mortality and stillbirth in LIC. Finally, we review
current recommendations for interventions to reduce
these mortality rates in LIC.* Correspondence: Rlg88@columbia.edu
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Maternal mortality
In most LIC, the major medical causes of maternal mor-
tality, defined as deaths to the mother during pregnancy
or in the first 42 days after birth, are hemorrhage, hyper-
tensive diseases of pregnancy and various types of ma-
ternal infections [6,8]. Hemorrhage is often classified
according to timing, i.e., occurring in the antepartum/
intrapartum or during the post-partum period. The most
common antenatal/intrapartum cause is placental abrup-
tion, while the most common cause of post-partum
hemorrhage is failure of the uterus to contract after de-
livery or uterine atony [8,9]. The most dangerous hyper-
tensive disease of pregnancy is preeclampsia, which may
lead to a number of potentially deadly complications includ-
ing strokes and seizures (eclampsia) [10]. Maternal infection
includes bacterial sepsis, HIV, malaria, syphilis, and various
other infections. Additionally, two other obstetric conditions
are related to maternal mortality from hemorrhage and in-
fection. Obstructed or prolonged labor may lead to maternalMed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Maternal mortality, 1900–2000, in select high-income
countries. Adapted from Goldenberg [6].
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uterine rupture. Women who undergo unsafe abortion may
also die from complications of hemorrhage and infection.
Stillbirth
Stillbirth, variably defined as deaths in utero from after
20 to 28 weeks gestation - depending on local standards,
often results from maternal complications [11-13]. The
most common maternal conditions leading to stillbirth
include hypertensive diseases of pregnancy, especially
preeclampsia and eclampsia, placental abruption, and
various types of maternal infection, such as syphilis and
malaria. Thus, most stillbirths result from asphyxia prior
to or during labor, often associated with hypertensive
diseases, abruption, obstructed or prolonged labor, and
obstetric complications such as breech presentation and
umbilical cord accidents. Treatment of maternal condi-
tions, e.g., early delivery for preeclampsia, may reduce
the associated fetal mortality but increase the risk of pre-
maturity. Placental lesions, especially necrosis and throm-
bosis, but also placental signs of hemorrhage, are often
discovered on placental histological examination in cases
of stillbirth and some authors attribute the majority of
fetal deaths to a placental abnormality [14,15].
Neonatal mortality
Neonatal mortality, defined as death to a live-born baby
within 28 days of life, in LIC is typically ascribed to three
major causes: infection, asphyxia and prematurity [16].
The most common type of infections causing mortality
are bacterial such as group B streptococcus (GBS), often
acquired during labor, but infections causing mortality
also may include malaria, syphilis, and tetanus [17,18].
Neonatal asphyxia is predominantly caused by maternal
complications such as abruption, or preeclampsia [19].
Among preterm infants, conditions that contribute to
mortality include 1) respiratory distress syndrome (RDS),
2) intraventricular hemorrhage (IVH), 3) necrotizing en-
terocolitis, and 4) infections [7,20,21]. In summary, a ma-
jority of all neonatal deaths are associated with one of the
maternal or fetal conditions described above.
History of pregnancy outcome improvements in high
income countries and evidence-based interventions for
low-income countries
Maternal mortality: history
Significant reductions in maternal, fetal and neonatal
mortality in HIC and many MIC’s have occurred during
the last century. In these countries, until about 1935,
maternal mortality ratios ranged from 500 to 1000
deaths per 100,000 births, i.e., nearly 1% of pregnant
women died (Figure 1) [6,22-24]. Until about 1935, this
situation in many countries had remained essentially un-
changed for hundreds of years, although slow reductionsin maternal mortality in Sweden have been attributed to
the introduction of trained midwives [22]. In recent
years, many HIC have reported maternal mortality ratios
of about 10/100,000 births or less [1].
Several papers have explored this reduction from 1935
through 1970–1980 [6,22-24]. Interventions responsible
for the reductions included the introduction of prenatal
care and hospitalization for delivery (1920’s and 1930’s),
antibiotics to treat infection (late 1930’s and 1940’s), and
uterotonics and blood transfusion (1940’s) (Figure 2).
The management of preeclampsia/eclampsia steadily im-
proved during the 1940’s to 1950’s with prenatal care to
diagnose the condition (blood pressure measurements
and urine protein determination), hospitalization to
monitor the condition, and a transition from watchful
waiting to immediate delivery for severe or progressing
disease. With antibiotics, blood availability, and improve-
ments in anesthesia, cesarean sections became safer and
were more commonly used to terminate life-threatening
pregnancies, such as those with prolonged labor or
eclampsia. Thus, beginning around 1935, introduction of
new, effective interventions were associated with signifi-
cant decreases in maternal mortality. As these interven-
tions were implemented, first in high-income and then in
some middle-income countries, nearly a 99% reduction in
maternal mortality was observed in these settings.Maternal mortality: evidence-based recommendations
Prevention of hemorrhage, the leading cause of maternal
mortality, can be accomplished through cesarean section
for prolonged labor and the reduction of unsafe abor-
tions [25,26]. For abortion-related complications, uterine
suction or curettage, antibiotics, blood and sometimes
hysterectomy prevent maternal mortality [26]. Use of
uterotonics, such as misoprostol or oxytocin at delivery,
can reduce post-partum hemorrhage associated with an
atonic uterus [27]. The case fatality rate associated with
hemorrhage may also be reduced through a reduction in
anemia, usually accomplished prenatally with iron and
Figure 2 Interventions associated with historical reduction in maternal mortality, United States, 1900–2000. Adapted from Johnson 2001 [23].
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tions in mortality from hemorrhage usually occur with
appropriate treatment of hemorrhage once it occurs.
Treatment varies with the cause of the hemorrhage and
may include surgery for lacerations or a ruptured uterus,
manual removal, suction or curettage for a retained pla-
centa or placental fragments, uterotonics to treat
hemorrhage from an atonic uterus, and for antepartum
hemorrhage due to a placental abruption or previa, a
cesarean section [9]. Hysterectomy (and sometimes other
abdominal procedures) is the surgery of last resort for
many types of obstetric hemorrhage. Also for hemorrhage
of any type, blood products are often life-saving. An im-
portant message is that even within a single condition
such as hemorrhage, there are many causes requiring sub-
stantial provider skills to assess the appropriate prevention
and treatment. No single intervention is likely to have a
large impact on hemorrhage-related maternal mortality.
After hemorrhage, the most frequent cause of mater-
nal mortality is hypertensive disease, and particularly
preeclampsia and eclampsia [10]. Prevention may be
possible through maternal treatment with calcium and
aspirin, but effectiveness of these interventions remains
uncertain. Women die from many complications of pre-
eclampsia/eclampsia including asphyxia during seizures,
aspiration pneumonia, strokes and cardiac, liver and kid-
ney failure, as well as hemorrhage secondary to clotting
disorders and placental abruption [29]. Since preeclamp-
sia is often asymptomatic until late in its course, diag-
nosing this condition early is the key to saving maternal
lives. Since the condition is generally defined by hyper-
tension and proteinuria, tests for both, repeated in pre-
natal care throughout the second half of pregnancy are
required to effectively diagnose this condition. Oncepreeclampsia is diagnosed, close observation with deliv-
ery by induction of labor or cesarean section for worsen-
ing disease is often life-saving. Magnesium sulfate
reduces initial and repeat seizures and may provide time
to affect delivery prior to new or recurrent seizures [30].
Thus, a combination of prenatal care to diagnose the
condition and facility care for delivery with labor induc-
tion and cesarean section capabilities are necessary to
reduce maternal mortality from this condition.
Infection is the third major killer of mothers [31-33].
Malaria is an important cause of maternal death in en-
demic areas, and can be responsible for maternal deaths
both during acute malarial episodes and after the acute
episode due to its effect on maternal anemia [31]. Most
important, however, are the bacterial infections of the
uterus [32]. During and immediately after the delivery,
the uterus provides an excellent culture medium for bac-
teria, and uterine infections are very common. The use
of non-sterile delivery techniques, prolonged labor, and
instrumentation including cesarean section all increase
the risk of infection [34]. Prevention of infection in-
cludes use of clean delivery sites, provider hand washing,
and avoiding prolonged labors and instrumentation
whenever possible. Treatment generally consists of the
timely administration of appropriate antibiotics.
In summary, most maternal deaths can be prevented
by decreasing the prevalence of the conditions that cause
the deaths or providing appropriate treatment for those
conditions. Since, with a few important exceptions, most
complications leading to maternal death cannot be pre-
dicted or prevented, care for these conditions must be
readily available to all women. Most maternal deaths
occur during labor, delivery and in the immediate post-
partum period [6,24]. When the conditions causing
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treatments for these conditions need to be readily avail-
able during labor and after delivery. Few of these inter-
ventions are available in the home and unfortunately, in
most LICs, many of these interventions are not available
in the clinics and even in some hospitals. For these rea-
sons, many have advocated for hospital deliveries, with
these interventions available [35,36].
Fetal mortality: history
In HIC, until about 1930, the fetal mortality rates gener-
ally ranged from 35 to 50/1000 births. In the recent Lancet
Stillbirth Series, nearly all HIC reported current stillbirth
rates of <5/1000 births with several countries reporting
rates as low as 2/1000, representing a reduction of ap-
proximately 90% over time [37,38]. As with maternal mor-
tality, the reduction in stillbirth began about 1935,
continued relatively rapidly until about 1980, and then has
continued more slowly until the present (Figure 3). Since
the cause of death for a stillbirth is often less clear than
for a maternal death, defining the interventions respon-
sible for the majority of the reduction is more difficult.
However, the interventions responsible for some of the re-
duction in fetal death rates are clear [39-41]. For example,
in the 1920’s, syphilis reportedly accounted for up to 20%
of US stillbirths. Today in HICs syphilis is rarely a cause a
stillbirth. Eighty years ago, in HIC, preeclampsia and
eclampsia were the major cause of fetal mortality, but
today account for only a small percentage of a much
smaller number of stillbirths. Rh disease was until the
1960’s an important cause of stillbirth. With routine Rho-
gam (anti-D) prophylaxis for Rh negative mothers, and
fetal transfusion for severely affected fetuses, stillbirth due
to Rh disease is rare. Stillbirths associated with abruption
also have been much reduced. Monitoring the fetus for
signs of asphyxia prenatally and during delivery, usingFigure 3 Historical stillbirth rates for high-income countries. Reprintedvarious techniques such as fetal heart rate monitoring,
with delivery for signs of distress, has reduced asphyxia-
related fetal mortality. The high rates of cesarean section
and labor induction in many HIC occur in part to re-
duce risk of stillbirth. Thus it appears that with appro-
priate care for the mother, stillbirth rates have been
reduced by up to 90%.
Fetal mortality: evidence based recommendations
As noted, most stillbirths in LIC are caused by intrauter-
ine asphyxia with a smaller percentage due to infection
and an even smaller percentage due to congenital anom-
alies. Many of the maternal conditions discussed above
lead to fetal asphyxia including prolonged labor, pre-
eclampsia/eclampsia and placental abruption. Pregnancy
complications such as growth restriction, abnormal pre-
sentations, multiple fetuses, and cord complications also
kill fetuses through asphyxia. Appropriate obstetric care
including monitoring for signs of asphyxia - often with
cesarean section for fetal distress - can prevent many
stillbirths. Fetal deaths due to infection can in certain
cases be prevented. For example, diagnosing and treating
maternal syphilis, preventing maternal malaria with bednets
and intermittent prophylaxis, and eliminating prolonged
labor to reduce asphyxia and bacterial chorioamnionitis, all
have a role in reducing stillbirths. With the possible excep-
tion of treatment for maternal GBS infection or membrane
rupture, maternal antibiotic administration has a smaller
role, if any, in preventing stillbirths. Since poor fetal growth
is often associated with stillbirth, some studies suggest that
maternal nutritional support that increases fetal growth
might result in a reduction in stillbirths [28].
Neonatal mortality: history
Neonatal mortality in HIC has also fallen substantially in
the last 80 years [42]. In 1935, the neonatal mortalityfrom Goldenberg, 2011 [46].
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the neonatal mortality rate in most HIC has been ap-
proximately 3-5/1000 live births. The decline is related
both to a decreasing prevalence of some conditions and
better treatment for others. About one-third of neo-
natal mortality is associated with preterm birth. Be-
cause in HIC the incidence of prematurity has, if
anything, increased over the last three decades, reduc-
tion in the prevalence of preterm birth is unlikely to be
associated with the decreased mortality [20]. Figure 4
depicts the major advances in care for preterm infants,
when they were introduced and the proportion of this
decrease likely due to these interventions. Beginning in
about 1960, treatment of RDS with oxygen, and later
with various types of ventilation support including con-
tinuous positive airway pressure (CPAP) and mechan-
ical ventilation, and still later, artificial surfactant,
substantially lowered the death rate from RDS [7]. In
HICs beginning in the 1990’s, increasing use of mater-
nal corticosteroids prior to delivery for women at risk
of preterm delivery substantially lowered the incidence
of RDS. The incidence of infection in preterm as well
as term newborns was also reduced with increased
clean delivery practices and the use of antibiotics [43],
saving many lives. Maternal treatment for syphilis and
vaccination for tetanus also contributed to the reduc-
tion of newborn infection-related mortality [44]. The
incidence of newborn asphyxia was substantially re-
duced with better obstetric care including monitoring
for hypoxia prenatally and during labor, and use of
cesarean sections for the indication of fetal distress.
Newborn resuscitation techniques improved and treat-
ment of asphyxia also reduced mortality [45]. Thus, as
seen with maternal and fetal mortality, from about
1935 onward, neonatal mortality rates significantly de-
creased in HIC.Figure 4 Estimated reductions in RDS-associated mortality with vario
from Kamath B [7].Neonatal mortality: evidence based implications
As noted, neonates in LIC die from three major
causes; asphyxia, infection, and preterm birth. As-
phyxia is best prevented; the same maternal interven-
tions that reduce stillbirth also reduce the prevalence
of neonatal asphyxia [46]. Thus, appropriate care for
women with obstructed or prolonged labor, abruption,
preeclampsia/eclampsia, or for fetal growth restriction
will not only reduce stillbirths, but also neonatal as-
phyxia and neonatal mortality. Neonatal resuscitation
is also important in reducing deaths of those infants
born with mild asphyxia [46]. Care for newborns with sig-
nificant asphyxia, including respiratory, temperature and
nutritional support, can save some additional lives. Thus,
appropriate treatment of maternal conditions as well as
newborn resuscitation and neonatal care can have a pro-
found impact on neonatal deaths from asphyxia.
Preventing deaths from neonatal infection also in-
volves multiple approaches, some directed at the mother
and some at the neonate. For example, preventing pro-
longed labor, treating the mother’s syphilis, immunizing
her against tetanus and giving antibiotics in the face of
maternal colonization with GBS or ruptured membranes
will all likely reduce neonatal infection and mortality.
The use of sterile/clean techniques including hand-
washing at the time of delivery and in the newborn period,
prophylactic antibiotics - especially in preterm infants and
appropriate cord care – now often with chlorhexidine, es-
pecially for home births - also reduce neonatal infections
and mortality [47]. For neonatal infections, antibiotic
treatment often proves lifesaving. Thus, to achieve sub-
stantial reductions in neonatal infection-related mortality,
a variety of maternal and newborn interventions are
needed.
The predominant cause of preterm neonatal mortal-
ity is RDS, but preterm infants also die from otherus interventions, by approximate year of introduction. Adapted
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bacterial infection [20]. While there are few if any in-
terventions that effectively prevent preterm births,
prevention of some of the above conditions associated
with preterm birth is possible. Depending on the set-
ting, corticosteroids given to the mother in the days
prior to delivery may prevent 30% of RDS as well as
necrotizing enterocolitis, IVH and neonatal mortality
[48]. For those neonates with RDS, oxygen, ventilatory
support and surfactant can substantially reduce mor-
tality. Thus, a program for reducing mortality from
preterm birth also has maternal and neonatal compo-
nents, and when they are applied appropriately, much
of the preterm neonatal mortality currently occurring
in LIC can be eliminated.Summary of evidence-based interventions to reduce
mortality
The interventions needed to reduce maternal, fetal
and neonatal mortality are thus well known and there
is every reason to believe that if these were made
available within a system of care to pregnant women
and their newborns, pregnancy related mortality rates
in LIC should approach those in HIC [36]. These types
of reductions have been demonstrated in several coun-
tries in transition including China, Malaysia and Sri
Lanka [1,2,5]. The most important question that arises
is not which interventions should be introduced, but
how to make these interventions widely available with
high quality of care in low and middle income coun-
tries. All too often, studies suggest that while an inter-
vention may be available, it is performed on the wrong
patients, performed poorly or too late. Thus, not only
the coverage of an intervention, but also the quality
performance of that intervention is crucial. Finally, it
has become clear that introducing one intervention at
a time rarely reduces mortality significantly. Instead,
developing an understanding of the population that
needs to be served and the capabilities within the sys-
tem to provide care to that population is an appropri-
ate starting point in any geographic area. Often
termed “the systems approach” there is substantial evi-
dence that defining the population, the goals of that
care, the resources and personnel available in the
clinics, hospitals, and in the home, and then creating a
system of care - provides the most success in reducing
maternal, fetal and neonatal mortality [49]. In sum-
mary, to save the life of a mother, fetus or neonate
with any particular condition, the condition must ei-
ther be prevented or be diagnosed and treated in an
appropriate and timely manner. Knowing the condi-
tions that kill mothers, fetuses and newborns and
when and where they die is therefore crucial.General recommendations
Based on the information detailed above, proposed lists
of interventions appropriate for low and middle-income
countries to reduce maternal, fetal, and neonatal mor-
tality, with estimates of potential lives saved, have been
proposed [36]. Figure 5, from the Lancet, estimates the
number of maternal, fetal and neonatal lives saved in
low-income countries with various interventions, and
emphasizes the importance of basic and emergency
care during labor and delivery. Since most maternal
and fetal as well as many neonatal deaths occur around
the time of delivery as shown in Figure 6 [50], the United
Nations has promoted two strategies to reduce mortality:
ensuring a skilled birth attendant at delivery and ensuring
prompt access to emergency obstetric care. Ideally, all
women would have access to essential obstetric care
which includes intrapartum monitoring with early detec-
tion and management or referral for complications
[Table 1]. In this description, basic essential emergency
obstetric care is comprised of 6 non-surgical functions in-
cluding parenteral antibiotics, parenteral oxytocic drugs,
parenteral anticonvulsants, manual removal of the pla-
centa, removal of retained products of conception, and
assisted vaginal delivery by forceps or vacuum extraction
[51]. Neonatal resuscitation is often included in this pro-
posed package. Comprehensive emergency obstetric care
would add blood transfusion and cesarean section to the
list. Staffing for basic emergency obstetric care would in-
clude at least two skilled birth attendants available
24 hours a day, seven days a week assisted by trained staff.
Comprehensive emergency obstetric care would require
staff trained to provide blood and perform a cesarean sec-
tion. Since saving many maternal, fetal and newborn lives
requires a cesarean section, timely access to this interven-
tion is crucial to achieve mortality rates comparable to
those seen in high-income countries.
Birth attendant capacity
Within any system of care, the capability of the birth
attendant is crucial to reducing maternal, fetal and
neonatal mortality. In low-income countries, historic-
ally, most often the birth attendant has been an un-
skilled or traditional birth attendant (TBA) [52]. For
the most part, studies have shown that even with add-
itional TBA training, the maternal mortality rates do
not decline substantially, although with training in re-
suscitation, there may be some reduction in stillbirth
and neonatal mortality [50,53]. For this reason, the
World Health Organization (WHO) and other organi-
zations have recommended the use of skilled birth at-
tendants for delivery. However, the training and skills
of these “skilled attendants” vary widely, and many
cannot perform a cesarean section, give blood or ad-
minister antibiotics, interventions often necessary to
Figure 5 Potential maternal, fetal and neonatal lives saved by obstetric and newborn interventions. Adapted from Pattinson R, 2011 [38].
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tendant to save a life is limited if there is no blood or
antibiotics, or if the facilities necessary to do a
cesarean section are not available. While a full review
is beyond the scope of this manuscript, it should beFigure 6 Intrapartum-related maternal, fetal and neonatal mortality. Robvious that in creating an effective system of care,
great attention must be paid to the skill level of the
birth attendant and the circumstances in which that
attendant will attempt to provide life-saving care to
the mother, fetus and newborn.eprinted from Lawn et al. [53].
Table 1 Components of basic and comprehensive
emergency obstetric care
Basic* Comprehensive
Parenteral antibiotics All components of Basic
Parenteral oxytocic drugs Blood transfusion
Parenteral anticonvulsants Cesarean Section
Manual removal of the placenta
Removal of retained products of conception
Assisted vaginal delivery by forceps or vacuum
*Neonatal resuscitation is often included in this proposed package.
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In low-income countries, one of the major obstacles to
program development aimed at improving pregnancy re-
lated outcomes is lack of reliable data on these out-
comes, the causes of these outcomes and the coverage
existing for the interventions that might improve these
outcomes. Without these types of data, and the ability
for a hospital, a geographic area, or a political district to
compare their outcomes with other similar entities, the
likelihood that improvement will occur is much reduced
[54]. Without the ability for these entities to compare
current outcomes to those achieved historically, the im-
pact of newly introduced programs or interventions will
not be understood. Only with reliable data used to focus
attention on continuous quality of care improvement, is
it likely that sustained improvement will occur. In virtu-
ally every geographic area where reductions in maternal,
fetal and neonatal mortality have occurred, improve-
ments in care and outcomes have gone hand in hand
with the development of data systems that capture out-
comes, causes of poor outcomes and intervention
coverage.
Conclusions
There is substantial information about the medical inter-
ventions that if widely used and used correctly couldTable 2 Major killers of mothers, fetuses and newborns in
low-income countries
Condition Mother Fetus Newborn
Hemorrhage X X X
Preeclampsia/eclampsia X X X
Intrauterine infection X X X
Obstructed Labor X X X
Fetal asphyxia X X
Preterm labor/birth X X
Syphils X X
Malaria X X
Adapted from Goldenberg, 2011 [46].save many maternal, fetal and neonatal lives. This review
also emphasizes that there is no single intervention
which will save the majority of lives. Instead, multiple
interventions throughout the pregnancy, or even be-
fore (family planning) – but especially during delivery,
are needed to save lives. Another observation that
arises from the review is that the maternal conditions
that cause maternal, fetal and neonatal deaths are
often the same, as are the treatments to prevent those
deaths [Table 2]. Thus, programs focused on reducing
all types of pregnancy-related mortality would be more
efficient than separate maternal mortality, stillbirth or
neonatal mortality reduction programs. Since many of
the conditions that kill mothers, fetuses, and new-
borns cannot be predicted or prevented, ideally all
women and newborns should have immediate or rapid
access to the interventions that save lives, which for
the most part are hospital based. Creating a structure
by which these interventions can be appropriately ap-
plied to all women and newborns in a timely fashion is
the challenge for any low-income country to achieve
substantial reductions in maternal, fetal and neonatal
mortality [38,40].
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